CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.
about
Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular PerspectivesA meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancerInterstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms.CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasisB7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancerCCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasisSIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migration.Examination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.Clinicopathological significance of CXCR4 in non-small cell lung cancer.CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitroTargeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.Characterization of a murine model of metastatic human non-small cell lung cancer and effect of CXCR4 inhibition on the growth of metastasesDifferential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells.Endothelial CXCR7 regulates breast cancer metastasisCXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.Overexpression of eukaryotic translation initiation factor 4E-binding protein 1 induces the alteration of immune status in H1299 lung cancer cellsAssociation of chemokine and chemokine receptor expression with the invasion and metastasis of lung carcinomaInverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancyAndrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Comparison of (18)F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression.Molecular targets and signaling pathways regulated by interleukin (IL)-24 in mediating its antitumor activities.The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcomeCXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells.Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.Pomolic Acid Inhibits Invasion of Breast Cancer Cells Through the Suppression of CXC Chemokine Receptor Type 4 Expression.CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer.CXCL12 secreted from glioma stem cells regulates their proliferation.Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver.Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.Expression of the CXCR4 ligand SDF-1/CXCL12 is prognostically important for adenocarcinoma and large cell carcinoma of the lung.Expression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy.CXCR4 chemokine receptor overview: biology, pathology and applications in imaging and therapy.Expression of CXCR4 and VEGF-C is correlated with lymph node metastasis in non-small cell lung cancer.CXCR7 regulates breast tumor metastasis and angiogenesis in vivo and in vitro.Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway.Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists.
P2860
Q26782778-854C2D06-2E77-4908-B1B7-5497960D17B7Q26998677-AECE3AA7-75A1-4A31-9268-96C39FDCC76EQ30275623-96D7C615-5219-4277-B1B0-3E4263AEBDB2Q34151630-C26DA86B-1BA6-4B4A-BFD3-4D6CC25AE964Q34459048-DA89DB3E-58D4-403F-BD1D-E13DA0B8446CQ34654463-EB01241C-E1E0-4C95-8438-4AB90E9DE0DDQ35042352-13F5BF83-1BF7-4E0E-B85D-83D351E5174BQ35167546-4D719908-FFC0-467B-89E6-E91737D28175Q35171366-34B9BD35-BAE5-40B8-95AB-7F76843341AFQ35181573-C9CDF38C-9447-47FD-856E-0D49F75C4DA6Q35213463-3D39E5BE-F91A-491A-BB11-F9BFBB1F5A78Q35376170-6A0C7CD4-773D-4A5F-B629-E06122D118C6Q35550241-24D6A074-D3E5-43EA-8EE6-CD009B413699Q35793659-992BF6A7-6C79-4B5C-BF5D-44BBD6A4B8C6Q35801242-055EDD2C-B03C-4D57-A48E-FD080C34D935Q35833218-E91A65AB-39C7-4ACC-8112-CC950468D338Q35879385-DC180746-8947-45AE-AAF8-77BBC3E585B4Q35943224-527AB91C-1E70-4342-ABFD-060FDA88F23CQ36413831-8914AC19-80B8-4933-9A0D-7F6756AD8593Q36838437-945E7156-CFFC-4D9A-9271-CDE93366C9B2Q37022167-F9AA0522-1AA2-4D60-AD18-E2BF3EF80C2EQ37236103-DEC9A8FC-3BED-4182-A466-3ABFCFE8434AQ37393337-3955C7C0-E01E-4F26-9977-8391E142CCD6Q38174692-40E36BAB-A0A8-4074-80D9-1220C91121ECQ38264982-074B63B0-E621-4DED-A63E-8B809379F7C2Q38673081-C10EFAB6-95D1-42A4-B5D8-AD08E1A39642Q38808628-B1B0069E-E445-4D5F-A80D-22ED19B46717Q38825599-BB5A18F6-ABD1-4A26-A10A-CF41D22AC316Q38831871-61E0FC4C-0A57-4A07-96B5-BFBE5250F2A6Q39032923-CFB592C2-DA79-4213-851E-155147A1AA29Q39064350-FF536C39-9551-44C7-B60A-6232EF05A41CQ39321350-D1E9ED55-B043-4DD2-9040-DF74231B04FEQ40051508-7F5461E2-37D1-4AFB-A1AB-6F101689CDEFQ40449073-75E2162B-3F33-49A2-8868-CDBA76DA2662Q42545518-AE7BD517-B5C4-4883-9EE8-173112D20B4DQ47131381-766CE966-D69C-4996-A149-01B970FC97C4Q47235091-59AA3902-EDAA-4B8D-8E45-17761E1CA406Q47649124-D740CF5C-5A7C-4DE7-A64C-2135E4162233Q47850217-2524A8DC-9762-43F4-B077-34022D699DC5Q48531686-78538A01-3671-4465-BFEF-4BC763EA928F
P2860
CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
CXCR4/CXCL12 axis in non small ...... les and therapeutic potential.
@ast
CXCR4/CXCL12 axis in non small ...... les and therapeutic potential.
@en
type
label
CXCR4/CXCL12 axis in non small ...... les and therapeutic potential.
@ast
CXCR4/CXCL12 axis in non small ...... les and therapeutic potential.
@en
prefLabel
CXCR4/CXCL12 axis in non small ...... les and therapeutic potential.
@ast
CXCR4/CXCL12 axis in non small ...... les and therapeutic potential.
@en
P2093
P2860
P921
P356
P1433
P1476
CXCR4/CXCL12 axis in non small ...... les and therapeutic potential.
@en
P2093
P2860
P356
10.7150/THNO.4922
P5008
P577
2013-01-13T00:00:00Z